Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy: Baby MERIT

NCT07817186 is registered in ClinicalTrials.gov with Carelon Research as lead sponsor.

NCT NCT07817186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07817186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy: Baby MERIT
Lead sponsor
Carelon Research
Phase
Phase 3
Overall status
Not yet recruiting
Start date
August 1, 2027
Completion date
June 30, 2032
Enrollment
25 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hcm, heart failure (pediatric), noonan syndrome and other rasopathy